Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.8.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Cash flows from operating activities:    
Net loss $ (59,601) $ (26,979)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization 253 151
Intangible asset impairment charges   500
Amortization of debt discounts and issuance costs 3,740 3,604
Costs of warrants issued at IPO 5,790  
Write-off of debt discounts and issuance costs at IPO 10,132  
Change in fair value of warrant liability (7,114) (950)
Stock issued to dissenting shareholder   159
Stock-based compensation expense 16,089 1,730
Provision for doubtful accounts 107  
Changes in assets and liabilities:    
Accounts receivable (2,964) 1,257
Expenditures billable to clients (779) (2,164)
Prepaid expenses and other current assets (1,620) (305)
Accounts payable 1,017 (9,188)
Accounts media payments (778) 6,721
Client advances 1,636 (3,005)
Other accrued liabilities 2,181 1,714
Net cash used in operating activities (31,911) (26,755)
Cash flows from investing activities:    
Purchases of marketable securities (39,850)  
Capital expenditures (664) (37)
Intangibles assets acquired (3,034)  
Deposits for operating leases (779)  
Other   (100)
Net cash used in investing activities (44,327) (137)
Cash flows from financing activities:    
Net proceeds from common stock offerings 56,468  
Proceeds from exercise of Primary Warrant 29,263  
Proceeds from the exercise of stock options 131 77
Deferred common stock offering costs   (136)
Debt issuance costs (68) (168)
Other (89)  
Net cash provided by financing activities 93,705 19,773
Increase (decrease) in cash and cash equivalents 17,467 (7,119)
Cash and cash equivalents, beginning of year 12,078 19,197
Cash and cash equivalents, end of year 29,545 12,078
Cash paid during the periods for:    
Income taxes 6 13
Non-cash investing and financing activities:    
Conversion of convertible notes payable, including accrued interest, to common stock 28,782  
Conversion of redeemable convertible preferred stock to common stock 27,266  
Unpaid deferred common stock offering costs 126 316
Bridge Loan [Member]    
Cash flows from financing activities:    
Proceeds from debt 8,000  
Convertible Notes Payable [Member]    
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Amortization of debt discounts and issuance costs $ 3,740 3,603
Cash flows from financing activities:    
Proceeds from debt   $ 20,000